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Response to Letter to Editor regarding
‘‘Depopulated Bovine Ureteric Xenograft for
Complex Haemodialysis Vascular Access’’
Dear Editors,
In reply
Thanking the authors for their comments. We had no
occlusions at all in the first 30 days. This is interesting as
the internal surface of the graft is exposed basement
membrane. Hence the early use of heparin should not
be required. The longer term use of warfarin may be
useful. However, we saw very few spontaneous occlu-
sions the majority being secondary to significant
patient systemic events or development of outflow
stenosis. Perhaps warfarin would have kept the graft
patent until it had become obvious that there was a
reduced flow/high venous pressure and maintained pa-
tency whilst intervention was arranged. Overall the
graft seems to have a low thrombogenicity. Out poor
primary patency relates largely to structural outflow
problems and the very poor condition of the cohort of
patients in which we felt it appropriate to use such
a novel graft. Secondary patency is acceptable but has
required a significant input to achieve. More recent pa-
tients as is often the case, seem to be faring better.
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Complex Haemodialysis Vascular Access
Dear Editors,
We read with interest the article by Mr C.R. Darby
et al. regarding the use of grafts made of bovine ure-
ters. We have also used these grafts but were forced
to stop recently due to a decision by the European li-
censing committee. Unlike Mr Darby’s experience,
which described a primary patency of 29% at one
year, we have had more success. Our primary patency
was substantially better, but the grafts often required
radiological re-intervention.1 We believe that a liberal
use of heparin infusion during the primary pro-
cedure e initiated when the arterial clamps are re-
moved and continued for two postoperative days e
have contributed to our more favourable experience.
We also put the patients on Warfarin or Aspirin for
a period of 3e6 months after surgery.
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